The term CIITA Activators refers to a class of chemical compounds that possess the unique ability to interact with and modulate the activity of the class II major histocompatibility complex transactivator (CIITA). CIITA is a key transcriptional regulator in the immune system and plays a crucial role in the expression of major histocompatibility complex class II (MHC-II) genes. MHC-II molecules are essential for antigen presentation, a critical process in the adaptive immune response, where they display fragments of foreign proteins (antigens) to T cells, enabling the immune system to recognize and respond to pathogens. CIITA activators, therefore, are compounds that can influence the expression of MHC-II genes by modulating the activity of CIITA, thereby impacting the immune system's ability to recognize and respond to antigens.
The mechanism of action of CIITA activators typically involves their ability to enhance or inhibit the transcriptional activity of CIITA. This transcription factor regulates the expression of MHC-II genes by binding to their promoter regions and initiating their transcription. CIITA activators may interact with CIITA directly or with other regulatory proteins involved in the CIITA-mediated transcriptional pathway. By doing so, they can either enhance the expression of MHC-II genes, leading to increased antigen presentation, or inhibit CIITA's activity, reducing the presentation of antigens to T cells. Understanding the properties and effects of CIITA activators is fundamental in immunology research, as it sheds light on the regulation of antigen presentation and the intricate mechanisms that govern immune responses against pathogens and foreign substances.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol can enhance MHC class II expression, potentially influencing CIITA activity indirectly. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin impacts inflammatory pathways, potentially affecting CIITA-mediated gene expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates cAMP pathways, which might intersect with CIITA-regulated pathways. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Cholecalciferol modulates immune responses, potentially affecting CIITA activity. | ||||||
Butyric acid | 107-92-6 | sc-214640 sc-214640A | 1 kg 10 kg | $64.00 $177.00 | ||
Butyric acid, a histone deacetylase inhibitor, can influence gene expression, potentially affecting CIITA. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone, a PPAR-gamma agonist, may indirectly influence CIITA activity through PPAR-gamma pathways. | ||||||
Roflumilast | 162401-32-3 | sc-208313 | 5 mg | $60.00 | 21 | |
Roflumilast, a PDE4 inhibitor, may intersect with pathways involving CIITA. | ||||||